MedAbbrev, now by innoviHealth, has been the industry standard for medical abbreviations and acronyms since 1983. Quick and easy access for hospitals, providers, coders, transcriptionists, students and researchers to over 75,000 entries. With clear and accurate standardization that is always current, medical professionals can reduce the chance of error stemming from misunderstood abbreviations.
Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy
If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month period.